Glucovance 500mg/5mg Tablets Film-Coated Tablet Kenya - English - Pharmacy and Poisons Board

glucovance 500mg/5mg tablets film-coated tablet

merck (pty) ltd 1 friesland drive, longmeadow business estate - metformin hydrochloride; glibenclamide - film-coated tablet - 500mg/5mg - combinations of oral blood glucose lowering drugs

Glucovance 250mg/1.25 mg Namibia - English - Namibia Medicines Regulatory Council

glucovance 250mg/1.25 mg

merck (pty) ltd sa - glibenglamide, metformin hydrocchloride - tablets - each tablet contains glibenglamide 1.25mg, metformin 250 mg

Glucovance 500mg/2.5 mg Namibia - English - Namibia Medicines Regulatory Council

glucovance 500mg/2.5 mg

merck (pty) ltd sa - glibenglamide, metformin hydrocchloride - tablets - each tablet contains glibenglamide 2.5 mg, metformin 500 mg

Glucovance 500mg/5.0 mg Namibia - English - Namibia Medicines Regulatory Council

glucovance 500mg/5.0 mg

merck (pty) ltd sa - glibenglamide, metformin hydrocchloride - tablets - each tablet contains glibenglamide 5.0 mg, metformin 500 mg

CIPROFLOXACIN- ciprofloxacin hydrochloride tablet, film coated United States - English - NLM (National Library of Medicine)

ciprofloxacin- ciprofloxacin hydrochloride tablet, film coated

hhs/program support center/supply service center - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 500 mg - ciprofloxacin tablets, usp are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below. please see dosage and administration for specific recommendations. urinary tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, serratia marcescens, proteus mirabilis, providencia rettgeri, morganella morganii, citrobacter diversus, citrobacter freundii, pseudomonas aeruginosa, methicillin-susceptible staphylococcus epidermidis, staphylococcus saprophyticus, or enterococcus faecalis. acute uncomplicated cystitis in females caused by escherichia coli or staphylococcus saprophyticus. chronic bacterial prostatitis caused by escherichia coli or proteus mirabilis. lower respiratory tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, pseudomonas aeruginosa, haemophilus influenzae, haemophilus parainfluenzae, or penicillin-sus

CIPROFLOXACIN tablet, film coated United States - English - NLM (National Library of Medicine)

ciprofloxacin tablet, film coated

hhs/program support center/supply service center - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 500 mg - ciprofloxacin tablets are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below. please see dosage and administration for specific recommendations. urinary tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, serratia marcescens, proteus mirabilis, providencia rettgeri, morganella morganii, citrobacter diversus, citrobacter freundii, pseudomonas aeruginosa, methicillin-susceptible staphylococcus epidermidis, staphylococcus saprophyticus, or enterococcus faecalis. acute uncomplicated cystitis in females caused by escherichia coli or staphylococcus saprophyticus . chronic bacterial prostatitis caused by escherichia coli or proteus mirabilis . lower respiratory tract infections caused by escherichia coli , klebsiella pneumoniae , enterobacter cloacae , proteus mirabilis , pseudomonas aeruginosa , haemophilus influenzae , haemophilus parainfluenzae , or penicil

CIPROFLOXACIN- ciprofloxacin hydrochloride tablet, film coated United States - English - NLM (National Library of Medicine)

ciprofloxacin- ciprofloxacin hydrochloride tablet, film coated

hhs/program support center/supply service center - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 500 mg - ciprofloxacin tablets, usp are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below. please see dosage and administration   for specific recommendations. adult patients urinary tract infections caused by escherichia coli , klebsiella pneumoniae , enterobacter cloacae , serratia marcescens , proteus mirabilis , providencia rettgeri , morganella morganii , citrobacter diversus , citrobacter freundii , pseudomonas aeruginosa , methicillin-susceptible staphylococcus epidermidis , staphylococcus saprophyticus , or enterococcus faecalis . acute uncomplicated cystitis in females caused by escherichia coli or staphylococcus saprophyticus. chronic bacterial prostatitis caused by escherichia coli or proteus mirabilis. lower respiratory tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, pseudomonas aeruginosa, haemophilus influenzae, haemophilus parain

CIPROFLOXACIN- ciprofloxacin hydrochloride tablet, film coated United States - English - NLM (National Library of Medicine)

ciprofloxacin- ciprofloxacin hydrochloride tablet, film coated

hhs/program support center/supply service center - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin tablets, usp are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below. please see dosage and administration for specific recommendations. urinary tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, serratia marcescens, proteus mirabilis, providencia rettgeri, morganella morganii, citrobacter diversus, citrobacter freundii, pseudomonas aeruginosa, methicillin-susceptible staphylococcus epidermidis, staphylococcus saprophyticus, or enterococcus faecalis. acute uncomplicated cystitis in females caused by escherichia coli or staphylococcus saprophyticus. chronic bacterial prostatitis caused by escherichia coli or proteus mirabilis. lower respiratory tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, pseudomonas aeruginosa, haemophilus influenzae, haemophilus parainfluenzae, or penicillin-sus